Equity (Schedule of Restricted Stock Activity) (Details) (USD $)	3 Months Ended
	Dec. 31, 2013
Number of Shares
Non-vested as of December 31, 2013 (in shares)	739,209
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock awards, vesting period	3 years
Number of Shares
Non-vested as of September 30, 2013 (in shares)	99,561
Granted (in shares)	0
Vested (in shares)	0
Forfeited (in shares)	(1,227)
Non-vested as of December 31, 2013 (in shares)	98,334
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2013 (in dollars per share)	$ 5.84
Granted (in dollars per share)	$ 0.00
Vested (in dollars per share)	$ 0.00
Forfeited (in dollars per share)	$ 5.68
Non-vested as of December 31, 2013 (in dollars per share)	$ 5.85
Restricted Stock Disclosures:
Remaining unamortized stock-based compensation expense	$ 43,000
Remaining unamortized stock-based compensation expense, period for recognition (in years)	0 years 1 month 6 days
Restricted Stock Units
Number of Shares
Non-vested as of September 30, 2013 (in shares)	854,928
Granted (in shares)	60,000
Vested (in shares)	(152,300)
Forfeited (in shares)	(23,419)
Non-vested as of December 31, 2013 (in shares)	739,209
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2013 (in dollars per share)	$ 4.51
Granted (in dollars per share)	$ 4.95
Vested (in dollars per share)	$ 3.96
Forfeited (in dollars per share)	$ 4.41
Non-vested as of December 31, 2013 (in dollars per share)	$ 4.66
Restricted Stock Disclosures:
Remaining unamortized stock-based compensation expense	2,200,000
Remaining unamortized stock-based compensation expense, period for recognition (in years)	1 year 9 months 18 days
Outstanding non-vested RSUs aggregate intrinsic value	3,800,000
Outstanding non-vested RSUs weighted average remaining contractual term (in years)	1 year 0 months 0 days
Share-based compensation arrangement, by share-based payment award, options, vested and expected to vest, exercisable, number	700,000
Share based compensation arrangement, by share based payment award, equity instruments other than options, expected to vest, intrinsic value	$ 3,400,000
Share based compensation arrangement, by share based payment award, equity investments other than options, expected to vest, weighted average contractual term (in years)	1 year 9 months 18 days